SteadyMed Ltd. (STDY) Completes Trevyent Manufacturing Requirements for NDA Submsision
Tweet Send to a Friend
SteadyMed Ltd. (Nasdaq: STDY) announced that it has completed the manufacture of all of the Trevyent batches for shelf-life studies ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
